All In Biotech

Drug Trial Radar · NCT07431177

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase IIb Study to Assess the Efficacy and Safety of GIA632 in Adult Participants With Non-segmental Vitiligo Followed by an Extension Period

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 210 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

210

Planned (sponsor's estimate)

Start

Mar 9, 2026

Primary completion

Jun 6, 2028

Study completion Jan 28, 2030

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Feb 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this multicenter, randomized, double-blind, placebo-controlled Phase 2b study is to investigate the safety and efficacy of GIA632 in participants with NSV and to identify the optimal dose to be promoted into the confirmatory Phase 3 program.

Conditions

  • Non-segmental Vitiligo

Interventions

  • GIA632Drug

    GIA632 will be administered during the 48-week core period.

  • PlaceboDrug

    Placebo will be administered during the 48-week core period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage change from baseline in Facial Vitiligo Area Scoring Index (F-VASI) score.Time frame: Baseline, Week 24

Locations

85 sites in 12 countries. Site status is shown where the registry gives one.

  • Cahaba Derm and skin hlth ctr 27

    Birmingham, Alabama · Recruiting

  • First OC Dermatology

    Fountain Valley, California · Recruiting

  • MedDerm Associates

    San Diego, California · Recruiting

  • Clinical Trials Research Institute

    Thousand Oaks, California · Recruiting

  • Encore Medical Research

    Hollywood, Florida · Recruiting

  • Mayo Clinic Jacksonville

    Jacksonville, Florida · Recruiting

  • Miami Derm and Laser Institute

    Miami, Florida · Recruiting

  • Global Clinical Professionals

    St. Petersburg, Florida · Recruiting

  • Endeavor Health

    Glenview, Illinois · Recruiting

  • Dawes Fretzin Clinical Rea Group

    Indianapolis, Indiana · Recruiting

  • DermAssociates LLC

    Rockville, Maryland · Recruiting

  • Uni Of Michigan Health System

    Ann Arbor, Michigan · Recruiting

  • Hamzavi Dermatology

    Fort Gratiot, Michigan · Recruiting

  • Revival Research Institute

    Troy, Michigan · Recruiting

  • Skin Specialists PC

    Omaha, Nebraska · Recruiting

  • Las Vegas Dermatology

    Las Vegas, Nevada · Recruiting

  • Equity Medical

    The Bronx, New York · Recruiting

  • Oregon Medical Research Center

    Portland, Oregon · Recruiting

  • International Clinical Research Tennessee LCC

    Murfreesboro, Tennessee · Recruiting

  • Bellaire Dermatology Associates

    Bellaire, Texas · Recruiting

  • Center for Clinical Studies

    Houston, Texas · Recruiting

  • Austin Inst for Clinical Research

    Pflugerville, Texas · Recruiting

  • ACRC Trials

    Plano, Texas · Recruiting

  • Virginia Clinical Research

    Norfolk, Virginia · Recruiting

  • Novartis Investigative Site

    Caba, Argentina · Recruiting

  • Novartis Investigative Site

    San Miguel de Tucumán, Argentina · Recruiting

  • Novartis Investigative Site

    Buenos Aires, Buenos Aires, Argentina · Recruiting

  • Novartis Investigative Site

    Caba, Buenos Aires, Argentina · Recruiting

  • Novartis Investigative Site

    CABA, Buenos Aires, Argentina · Recruiting

  • Novartis Investigative Site

    Rosario, Santa Fe Province, Argentina · Recruiting

  • Novartis Investigative Site

    Sydney, New South Wales, Australia · Recruiting

  • Novartis Investigative Site

    Waitara, New South Wales, Australia · Recruiting

  • Novartis Investigative Site

    Melbourne, Victoria, Australia · Recruiting

  • Novartis Investigative Site

    Calgary, Alberta, Canada · Recruiting

  • Novartis Investigative Site

    Winnipeg, Manitoba, Canada · Recruiting

  • Novartis Investigative Site

    Mississauga, Ontario, Canada · Recruiting

  • Novartis Investigative Site

    Newmarket, Ontario, Canada · Recruiting

  • Novartis Investigative Site

    Toronto, Ontario, Canada · Recruiting

  • Novartis Investigative Site

    Québec, Quebec, Canada · Recruiting

  • Novartis Investigative Site

    Beijing, China · Recruiting

Showing 40 of 85 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.